Inflammatory Bowel Disease

  1. Home
  2. HBOT Research
  3. Inflammatory Bowel Disease

Explore the latest research on the use of Hyperbaric Oxygen Therapy (HBOT) to treat Inflammatory Bowel Disease. Extivita maintains an extensive publication database for Inflammatory Bowel Disease and various other indications with therapies such as Hyperbaric Oxygen Therapy, Neurofeedback, Nutritional IV Therapy, Infrared Sauna, and Pulsed Electromagnetic Field Therapy. Explore our database on Acne and Hyperbaric Oxygen Therapy aka, HBOT, below.

For a complete list of indications treated at Extivita, explore the conditions we treat.

Hyperbaric Oxygen Therapy Promising for Crohn’s Fistulas

Hyperbaric oxygen therapy (HBOT) can help heal bowel fistulas in patients with advanced Crohn's disease, according to a systematic review and meta-analysis. Overall, use of HBOT was associated with a 87% clinical response rate for all fistula subtypes, with more than...

read more
Ulcerative Colitis

Ulcerative Colitis

Diagnosis Endoscopic procedures with tissue biopsy are the only way to definitively diagnose ulcerative colitis. Other types of tests can help rule out complications or other forms of inflammatory bowel disease, such as Crohn's disease. To help confirm a diagnosis of...

read more
Stem cell-based therapy for inflammatory bowel disease

Stem cell-based therapy for inflammatory bowel disease

Abstract Inflammatory bowel disease (IBD) is an idiopathic, multi-etiological disease characterized by inflammation and mucosal destruction of the gastrointestinal tract. Despite the remarkable advance in immunomodulating therapies, there still remains a certain...

read more
Hyperbaric Oxygen for Hospitalized patients with Ulcerative Colitis.

Hyperbaric Oxygen for Hospitalized patients with Ulcerative Colitis.

One quarter of patients with ulcerative colitis will develop a severe acute exacerbation of disease during their lifetime. Despite high dose corticosteroids, half of these patients will fail subsequent medical rescue therapy, and half will require colectomy within 5 years. Dulai and colleagues report the results of a fascinating, double blind, sham controlled, proof of concept trial which demonstrated that administration of short term hyperbaric oxygen therapy (HBOT) at the point of presentation with severe UC was able to rapidly induce short term remission and avoid the need for urgent second line medical rescue therapy. Further dose finding studies are underway.

read more